LEP and juvenile idiopathic arthritis: The analysis of the effect of etanercept therapy on changes in plasma leptin levels in children with juvenile idiopathic arthritis over successive months of treatment revealed a gradual increase in the concentration of this adipocytokine in the blood of sick children observed up to the twenty-fourth month of therapy.